A Trial for Patients With Advanced/Recurrent Cervical Cancer

NCT00190983 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia
Uterine Neoplasms
Genital Neoplasms, Female

Interventions

DRUG: Pemetrexed

Sponsor

Eli Lilly and Company

Collaborators

[object Object]